Home Healthcare IT Southeast Asia Autoimmune Disease Diagnostics Market Size, Share And Growth Report By 2029

Southeast Asia Autoimmune Disease Diagnostics Market Size & Outlook, 2025-2029

Southeast Asia Autoimmune Disease Diagnostics Market Size

According to Straits Research analysis, the Southeast Asia Autoimmune Disease Diagnostics Market was valued at USD 262.61 Million in 2024 and is projected to reach USD 420.51 Million by 2029, expanding at a CAGR of 10% during the forecast period. The growth is propelled by increased healthcare spend, a surge in lifestyle diseases, and growing public awareness of autoimmune diseases. Widespread application of diagnostic methods, namely immunoassays and clinical chemistry, in sectors such as pharmaceuticals, research labs, and biotechnology compounds the demand. Recognizing emerging trends in green diagnostics and sustainability, Southeast Asia banks on its technological advancement in healthcare and strong export potential. The region is smartly leveraging this growth trajectory to better position itself on the global autoimmune disease diagnostics market.

Southeast Asia Autoimmune Disease Diagnostics Market Highlights

  • In 2024, Consumables & Assay Kits accounted for the highest share of the Product market size.
  • During the forecast period, Consumables & Assay Kits is set to register the highest growth, making it the most lucrative Product segment.
  • Southeast Asia contributed 4.77% to the global autoimmune disease diagnostics market size in 2024.
  • By 2029, United States is forecasted to remain the largest global market for autoimmune disease diagnostics market.
  • In Asia Pacific, China is projected to capture the leading share of market by 2029.
  • Among Asia Pacific markets, India is expected to post the fastest growth, reaching USD 58503 Million by 2029.
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2029
Historical Period 2021-2023
Forecast Period 2025-2029
Market Size In 2024 USD 262.61 Million
Market Size In 2029 USD 420.51 Million
Largest segment Consumables & Assay Kits
Fastest segment Consumables & Assay Kits
Units Revenue in USD Million
CAGR 10% (2025-2029)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Southeast Asia Autoimmune Disease Diagnostics Market Share By Product

Segmentation Covered

Segments Sub Segments
Product
  1. Consumables & Assay Kits
  2. Instruments
  3. Services
Test type
  1. Antinuclear Antibody Tests
  2. Autoantibody Tests
  3. Complete Blood Count (CBC)
  4. C-reactive Protein (CRP)
  5. Urinalysis
  6. Others Tests
Target disease
  1. Systemic Autoimmune Disease
  2. Localized Autoimmune Disease
Systemic Autoimmune Disease, by Type
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Systemic Lupus Erythematosus
  4. Multiple Sclerosis
  5. Others
Localized Autoimmune Disease, by Type
  1. Inflammatory Bowel Disease
  2. Type 1 Diabetes
  3. Thyroid
  4. Other Localized Autoimmune Diseases
End User
  1. Clinical Laboratories
  2. Hospitals
  3. Research Laboratories & Institutes
  4. Others
WhatsApp
Chat with us on WhatsApp